Diagnostic Medical announces a return to profitability in the first half of 2026

Diagnostic Medical Systems reported a significant improvement in profitability for the first half of 2026. EBITDA increased by 52%, reaching a margin of 11.7%. This result reflects the operational measures implemented by the company. Net income was positive, rising from -€0.1 million to €0.5 million.

Despite a 6% decline in revenue to €22.1 million, the company saw an improvement in bone densitometry with a 6% increase in sales. However, radiology sales fell by 9% due to a complex market environment in Europe.

Diagnostic Medical plans to maintain this positive trajectory with the objective of an EBITDA margin of 14% in 2027, despite current geo-economic uncertainties.